DE69006000D1 - Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln. - Google Patents

Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln.

Info

Publication number
DE69006000D1
DE69006000D1 DE90312217T DE69006000T DE69006000D1 DE 69006000 D1 DE69006000 D1 DE 69006000D1 DE 90312217 T DE90312217 T DE 90312217T DE 69006000 T DE69006000 T DE 69006000T DE 69006000 D1 DE69006000 D1 DE 69006000D1
Authority
DE
Germany
Prior art keywords
iontophoresis
drug delivery
topical drug
flow enhancer
transdermal flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90312217T
Other languages
English (en)
Other versions
DE69006000T2 (de
Inventor
Michael Lee Francoeur
Russell Owen Potts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69006000D1 publication Critical patent/DE69006000D1/de
Application granted granted Critical
Publication of DE69006000T2 publication Critical patent/DE69006000T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
DE90312217T 1989-11-29 1990-11-08 Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln. Expired - Fee Related DE69006000T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/443,699 US5023085A (en) 1989-11-29 1989-11-29 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals

Publications (2)

Publication Number Publication Date
DE69006000D1 true DE69006000D1 (de) 1994-02-24
DE69006000T2 DE69006000T2 (de) 1994-05-05

Family

ID=23761854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90312217T Expired - Fee Related DE69006000T2 (de) 1989-11-29 1990-11-08 Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln.

Country Status (17)

Country Link
US (1) US5023085A (de)
EP (1) EP0435436B1 (de)
JP (1) JPH0688912B2 (de)
KR (1) KR930007248B1 (de)
AT (1) ATE99961T1 (de)
AU (1) AU613281B1 (de)
CA (1) CA2030943A1 (de)
DE (1) DE69006000T2 (de)
DK (1) DK0435436T3 (de)
HU (1) HUT55629A (de)
IE (1) IE63597B1 (de)
IL (1) IL96449A (de)
MY (1) MY109727A (de)
NZ (1) NZ236253A (de)
PH (1) PH27105A (de)
PT (1) PT96021B (de)
ZA (1) ZA909512B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
DE3880923T3 (de) * 1987-02-23 1997-12-18 Shiseido Co Ltd Perkutaner absorptionspromotor und dermatologische zusammensetzung für externe anwendung.
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5302172A (en) * 1990-03-15 1994-04-12 North Carolina State University Method and composition for iontophoresis
US5383848A (en) * 1990-04-12 1995-01-24 Gensia, Inc. Iontophoretic administration of drugs
US6600950B1 (en) * 1990-11-01 2003-07-29 Robert Tapper Iontophoretic treatment system
US6575957B1 (en) * 1990-11-01 2003-06-10 Robert Tapper Iontophoretic treatment system
US6582416B2 (en) 1990-11-01 2003-06-24 Robert Tapper Iontophoretic treatment system
US6223076B1 (en) 1990-11-01 2001-04-24 Robert Tapper Sweat control system
US6139537A (en) * 1990-11-01 2000-10-31 Tapper; Robert Iontophoretic treatment system
US5224927A (en) * 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US6238381B1 (en) 1990-11-01 2001-05-29 Robert Tapper Iontophoretic treatment system
US6235013B1 (en) 1990-11-01 2001-05-22 Robert Tapper Iontophoretic treatment system
US5131403A (en) * 1991-06-05 1992-07-21 Becton Dickinson And Company Method for obtaining blood using iontophoresis
US5356632A (en) * 1991-09-12 1994-10-18 S.I. Scientific Innovations Ltd. Transdermal drug delivery device
EP0552879B1 (de) * 1992-01-21 1998-08-19 Macrochem Corporation Iontophoretische verbesserte Verabreichung von Medikamenten
CA2183875C (en) * 1992-06-02 2003-10-14 Robert M. Myers Electrotransport drug delivery device
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5594015A (en) * 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
ATE197396T1 (de) * 1994-07-13 2000-11-11 Alza Corp Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung
US5540654A (en) * 1994-09-02 1996-07-30 North Carolina State University Iontophoretic electrode
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6355025B1 (en) 1995-06-07 2002-03-12 Alza Corporation Adjustable electrotransport drug delivery using a fixed output controller
AU7286996A (en) * 1995-10-18 1997-05-07 Ciba-Geigy Ag Thermopile powered transdermal drug delivery device
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
AUPO907697A0 (en) * 1997-09-09 1997-10-02 Day, Robert Edward Chemical supplementation of bone
GB9723669D0 (en) 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
EP1135188B1 (de) 1998-11-02 2007-11-28 ALZA Corporation Iontophoretische vorrichtung mit einem materialverträglichen antimikrobiellen wirkstoff
JP2001072592A (ja) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
CA2400074A1 (en) 2000-02-18 2001-08-23 William I. Higuchi Methods for extracting substances using alternating current
EP1259285A1 (de) 2000-02-18 2002-11-27 University of Utah Verfahren zur abreichung von medikamenten durch wechselstrom
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
JP4320177B2 (ja) * 2001-04-04 2009-08-26 アルザ・コーポレーシヨン 抗微生物適合性レザバー組成物を含む経皮性電気輸送デリバリー装置
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20050220439A1 (en) * 2004-03-19 2005-10-06 Carton Owen A Interactive multimedia system and method
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
CA2613875C (en) * 2005-07-04 2018-09-25 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
US20070292492A1 (en) * 2006-06-16 2007-12-20 Friden Phllip M Pharmaceutical formulations for iontophoretic tetracycline antibiotic delivery
WO2009158477A1 (en) 2008-06-25 2009-12-30 Us Worldmeds Llc Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery
US20110281834A1 (en) * 2008-11-10 2011-11-17 Friden Phillip M Pharmaceutical Formulations for Iontophoretic Delivery of a Corticosteroid
US20100331812A1 (en) * 2009-06-29 2010-12-30 Nitric Biotherapeutics, Inc. Pharmaceutical Formulations for Iontophoretic Delivery of an Immunomodulator
EP2557924B1 (de) 2010-04-13 2019-06-12 Relmada Therapeutics, Inc. Dermale pharmazeutische zusammensetzungen aus 1-methyl-2',6'-pipecoloxylidid und verwendungsverfahren dafür
AU2014369916A1 (en) 2013-12-24 2016-06-16 Durect Corporation Uses of oxygenated cholesterol sulfates (OCS)
US11564970B2 (en) 2017-10-09 2023-01-31 The Broad Institute, Inc. Compositions and methods for combinatorial drug discovery in nanoliter droplets

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS6036299B2 (ja) * 1981-07-02 1985-08-20 タカラベルモント株式会社 イオン導入器
HU185691B (en) * 1982-02-09 1985-03-28 Richter Gedeon Vegyeszet Process for preparing a new analgetic pharmaceutical composition
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4919648A (en) * 1983-08-18 1990-04-24 Drug Delivery Systems Inc. High tack drug patch
JPS6222662A (ja) * 1985-07-19 1987-01-30 林原 健 イオン導入電子治療器
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
ATE80313T1 (de) * 1988-02-29 1992-09-15 Pfizer Mittel zur erhoehung des transdermalen penetrationsflusses.

Also Published As

Publication number Publication date
EP0435436A3 (en) 1992-01-08
IE904281A1 (en) 1991-06-05
JPH03176426A (ja) 1991-07-31
JPH0688912B2 (ja) 1994-11-09
PH27105A (en) 1993-03-16
IE63597B1 (en) 1995-05-17
NZ236253A (en) 1993-05-26
EP0435436A2 (de) 1991-07-03
PT96021B (pt) 1998-02-27
MY109727A (en) 1997-05-31
US5023085A (en) 1991-06-11
AU613281B1 (en) 1991-07-25
KR930007248B1 (ko) 1993-08-04
DK0435436T3 (da) 1994-02-28
ZA909512B (en) 1992-06-24
KR910009250A (ko) 1991-06-28
IL96449A (en) 1996-07-23
ATE99961T1 (de) 1994-01-15
PT96021A (pt) 1991-09-13
EP0435436B1 (de) 1994-01-12
DE69006000T2 (de) 1994-05-05
HUT55629A (en) 1991-06-28
CA2030943A1 (en) 1991-05-30

Similar Documents

Publication Publication Date Title
DE69006000D1 (de) Verstärker des transdermalen Flusses in Kombination mit Iontophorese für die topische Verabreichung von Arzneimitteln.
DE3688075T2 (de) Transdermales verabreichungssystem.
DE69401945D1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
ATE67417T1 (de) Medizinische einrichtung zur pulsatilen transdermalen verabreichung von biologisch aktiven wirkstoffen.
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
ATE214946T1 (de) Zusammensetzungen zur penetrationsförderung in der haut durch gebrauch von acryllactylaten
ATE63813T1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
EP0164998A3 (de) Mittel und Verfahren zur Erhöhung der transdermalen und transmembranen Penetration topischer und systemischer Wirkstoffe
DE3587698T2 (de) Pharmazeutische Präparate.
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
ES2059403T3 (es) Composicion util en el tratamiento de deficiencias de estrogenos.
ATE84714T1 (de) Transkutane verabreichung von pharmazeutika.
ATE50143T1 (de) Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
GR3004113T3 (de)
DE3771548D1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
ES2051788T3 (es) Un producto farmaceutico.
FR2579463B1 (fr) Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne
AP8500009A0 (en) New phenoxypropanolamine salts and pharmaceutical preparations thereof.
ATE94197T1 (de) Eindringungserhoehende mittel zur transdermalen verabreichung systemischer mittel.
IT8709417A0 (it) Preparati a base di ferro per uso topico nel trattamento di dermatosi acneiche e seborroiche.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee